BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,068,000 | -44.0% | 53,372 | -46.1% | 0.01% | -37.5% |
| Q2 2022 | $14,416,000 | -84.2% | 98,932 | -87.2% | 0.01% | -81.4% |
| Q1 2022 | $91,401,000 | -16.9% | 770,867 | -3.4% | 0.04% | -12.2% |
| Q4 2021 | $109,969,000 | +7.3% | 797,980 | +8.1% | 0.05% | 0.0% |
| Q3 2021 | $102,512,000 | +40.0% | 737,971 | -2.2% | 0.05% | +36.1% |
| Q2 2021 | $73,227,000 | +47.4% | 754,294 | +3.8% | 0.04% | +33.3% |
| Q1 2021 | $49,668,000 | +394.7% | 726,680 | +520.3% | 0.03% | +350.0% |
| Q4 2020 | $10,041,000 | -70.7% | 117,153 | -77.8% | 0.01% | -75.0% |
| Q3 2020 | $34,305,000 | -23.2% | 527,690 | -13.6% | 0.02% | -29.4% |
| Q2 2020 | $44,645,000 | +131.6% | 610,647 | +7.8% | 0.03% | +100.0% |
| Q1 2020 | $19,273,000 | -28.1% | 566,333 | +14.9% | 0.02% | 0.0% |
| Q4 2019 | $26,823,000 | +592.9% | 492,757 | +430.5% | 0.02% | +466.7% |
| Q3 2019 | $3,871,000 | -39.6% | 92,881 | -36.5% | 0.00% | -25.0% |
| Q2 2019 | $6,407,000 | -57.6% | 146,351 | -50.2% | 0.00% | -55.6% |
| Q1 2019 | $15,110,000 | +121.2% | 293,595 | +58.9% | 0.01% | +80.0% |
| Q4 2018 | $6,832,000 | -61.5% | 184,766 | -60.9% | 0.01% | 0.0% |
| Q3 2018 | $17,761,000 | +15.3% | 473,017 | +21.4% | 0.01% | +25.0% |
| Q2 2018 | $15,401,000 | +868.0% | 389,746 | +530.9% | 0.00% | +300.0% |
| Q1 2018 | $1,591,000 | +150.6% | 61,778 | +162.0% | 0.00% | – |
| Q4 2017 | $635,000 | -7.0% | 23,580 | +28.6% | 0.00% | – |
| Q3 2017 | $683,000 | +109.5% | 18,332 | +39.6% | 0.00% | – |
| Q2 2017 | $326,000 | – | 13,131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |